Nautilus Biotechnology Insiders Lose Out As Stock Sinks To US$2.47
Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored With the Academy for Radiology and Biomedical Imaging Research's Distinguished Investigator Award
Morgan Stanley Maintains Nautilus Biotechnology(NAUT.US) With Hold Rating, Maintains Target Price $5
Nautilus Biotechnology to Participate in the Inaugural Guggenheim Healthcare Conference
Express News | Nautilus Biotechnology Inc : Guggenheim Cuts Target Price to $4 From $6
TD Cowen Maintains Nautilus Biotechnology(NAUT.US) With Buy Rating